Clinical and metabolic effects and structural changes left ventricle and the common carotid arteries in hypertensive patients with type 2 diabetes in the dynamics of long-term combined therapy
Vol 74 No 1 (2017), Therapy
Vol 74 No 1 (2017)

Clinical and metabolic effects and structural changes left ventricle and the common carotid arteries in hypertensive patients with type 2 diabetes in the dynamics of long-term combined therapy

Therapy
Published July 29, 2020
T.G. Starchenko
Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”
I.A. Korniychuk
Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”
S.M. Koval
Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”
K.O. Iushko
Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”
V.V. Bozhko
Government Institution “L.T.MalayaTherapy National Institute of the National Academy of Medical Sciences of Ukraine”
O.I. Cigankov
Government Institution “L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”
PDF (Українська)

Keywords

еssential hypertension
type 2 diabetes
combination therapy

How to Cite

Starchenko, T., Korniychuk, I., Koval, S., Iushko, K., Bozhko, V., & Cigankov, O. (2020). Clinical and metabolic effects and structural changes left ventricle and the common carotid arteries in hypertensive patients with type 2 diabetes in the dynamics of long-term combined therapy. Experimental and Clinical Medicine, 74(1), 56-59. Retrieved from https://ecm.knmu.edu.ua/article/view/552
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The effects of long-term 12-month combination therapy on the clinical and metabolic parameters and parameters of cardiac and vascular remodeling in hypertensive patients with type 2 diabetes have been studied. The results of the study suggest that, given the different options long-term therapy, there were no progression of structural changes in the left ventricle of the heart and the common carotid arteries. Such data may be indicative of the effectiveness of proven options combination antihypertensive, lipid-lowering and antidiabetic drugs in patients with hypertension, occurring against a background of type 2 diabetes.
PDF (Українська)

References

. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension / G. Mancia, R. Fagard, K. Narkiewicz et al. // J. Hypertens. – 2013; Oct. – Vol. 31 (10). – P. 1925–1938.

Hypertensive target organ damage predicts incident diabetes mellitus / R. Izzo, G. de Simone, V. Trimarco et al. / Eur. Heart J. – 2013. – Vol. 34. – P. 8419–8426.

Свищенко Е.П. Блокаторы рецепторов ангиотензина II в лечении артериальной гипертензии / Е.П. Свищенко, Л.В. Безродная / Донецк: Изд. Заславский А.Ю., 2012. – 72 с.

Сиренко Ю.Н. Гипертоническая болезнь и артериальные гипертензии / Ю.Н. Сиренко. – Донецк: Изд. Заславский А.Ю., 2011.– 351 с.

On behalh of the ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients –ASCOT substudy / E.A. Dolan, A.V. Stanton, K.H. Parker et al. / J. Hypertension. – 2009. – Vol. 27. – P. 876–885.

Cardiovascular morbidity and mortality in the Losartan intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol / B. Dahlоf, R.B. Devereux, S.E. Kjeldsen et al. / Lancet. – 2002. – Vol. 359. – P. 995–1003.

Настанова з артеріальної гіпертензії / За ред. В.М. Коваленка, Є.П. Свіщенко, Ю.М. Сіренка. – К.: МОРІОН, 2010. – 492 с.

Nadruz W. Myocardial remodeling in hypertension / W. Nadruz // J. Human Hypertension. – 2015. – Vol. 29. – P. 1–6; doi:10.